Literature DB >> 6158713

Metabolism of a peptide of human myelin basic protein in the rabbit.

R M Bashir, J N Whitaker.   

Abstract

Material cross-reactive with myelin basic protein (BP) peptide 43-88 has been identified as a major BP-like antigen appearing in human cerebrospinal fluid during acute myelin injury. In an effort to develop a means for detecting this material in the more accessible body fluids of blood and urine, as well as to determine its metabolic fate, the manner in which rabbits handle human BP peptide 43-88 was investigated. Unlabeled peptide was administered intravenously, and its concentration in plasma was monitored by radioimmunoassay. In studies of 10 rabbits, the peptide disappeared from blood in two phases, the first showing a half-life of 6.0 +/- 1.2 minutes and the second a half-life of 51.6 +/- 5.4 minutes. Organ-exclusion experiments indicated a rapid clearance, predominantly by the kidney, for the peptide, with tubular reabsorption and cleavage into smaller peptide fragments a probable catabolic mechanism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6158713     DOI: 10.1212/wnl.30.11.1184

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.

Authors:  K Genç; D L Dona; A T Reder
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

2.  Treatment of experimental allergic encephalomyelitis with myelin basic protein: which route is best?

Authors:  S Levine; R Sowinski
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

3.  The renal degradation of myelin basic protein peptide 43-88 by two enzymes in different subcellular fractions.

Authors:  J N Whitaker; M A Heinemann; B G Uzman
Journal:  Biochem J       Date:  1982-03-01       Impact factor: 3.857

Review 4.  Myelin basic protein and multiple sclerosis.

Authors:  J N Whitaker
Journal:  Ital J Neurol Sci       Date:  1983-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.